首页> 外文期刊>Journal of neuro-oncology. >The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study
【24h】

The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study

机译:最大手术切除的预后值衰减成成人弥漫性胶质瘤的少突术亚组:多中心回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose Maximal surgical resection is associated with survival benefit in the majority of studies in adult diffuse glioma. This study aims to characterize the prognostic value of surgical resection in molecular subgroups of diffuse glioma. Methods 1178 patients with diffuse glioma from our centers and 422 from TCGA dataset were collected. The Kaplan-Meier analysis and multivariable Cox regression models were conducted to identify the prognostic value of surgical resection through different histological and molecular stratifications. Results Firstly, we confirmed progression-free survival (PFS) benefit associated with gross total resection (GTR) over subtotal resection (STR) in lower-grade glioma (HR 1.49; 95% CI 1.17-1.90; P = 0.001). Intriguingly however, we were unable to detect a significant PFS or overall survival (OS) benefit in oligodendroglioma (N = 397; HR 1.36; 95% CI 0.86-2.14; p=0.19 and HR 1.05; 95% CI 0.55-1.99; P = 0.89, respectively). Secondly, when analyzed in molecular subgroups, we were similarly unable to detect a significant PFS or OS benefit in IDH MT/codel subgroup (N = 269; HR 1.47; 95% CI 0.92-2.34; P = 0.11 and HR 1.54; 95% CI 0.78-3.05; P = 0.21, respectively), oligodendroglioma with IDH MT/codel subgroup (N = 233; HR 1.33; 95% CI 0.79-2.21; P = 0.28 and HR 1.16; 95% CI 0.53-2.54; P = 0.70, respectively) or other relevant subgroups. TCGA validation also showed a significant survival benefit in astrocytoma rather than oligodendroglioma. Exploratory RNAseq analysis displayed that fewer cell proliferation-related gene expression features were specific to oligodendroglioma. Conclusion These results suggest that the benefit of maximal surgery may be attenuated in patients within oligodendroglioma relevant subgroups because of the chemosensitive and indolent nature. The aggressive surgery accompanying with risk of neurologic morbidity may be unnecessary for these patients given the lack of survival benefit with gross total resection.
机译:目的最大手术切除与成人弥漫性胶质瘤大多数研究中的生存益处有关。本研究旨在表征弥漫性胶质瘤的分子亚组手术切除的预后值。方法收集了来自我们中心和422的1178例来自TCGA数据集的422患者。进行了KAPLAN-MEIER分析和多变量COX回归模型,以鉴定通过不同的组织学和分子分层进行手术切除的预后值。结果首先,我们确认了在较低级胶质瘤(HR 1.49; 95%CI 1.17-1.90; P = 0.001)中对小脑切除(STR)的总分解(GTR)相关的无进展存活(PFS)益处。然而,有趣的是,我们无法检测oligodendroglioma(n = 397; HR 1.36; 95%CI 0.86-2.14; P = 0.19和1.05; 95%CI 0.55-1.99; P = 0.19和HR 1.05; 95%CI 0.55-1.99; p分别= 0.89)。其次,当在分子亚组中分析时,我们类似地检测IDH MT / Codel子组中的显着的PFS或OS益处(n = 269; HR 1.47; 95%CI 0.92-2.34; P = 0.11和HR 1.54; 95% CI 0.78-3.05; p = 0.21分别),具有IDH MT / Codel亚组的oligodendroglioma(n = 233; HR 1.33; 95%CI 0.79-2.21; P = 0.28和HR 1.16; 95%CI 0.53-2.54; P = 0.70分别为0.70或其他相关亚组。 TCGA验证还显示出在星形细胞瘤而不是少压术中的显着生存益处。探索性RNASEQ分析显示,较少的细胞增殖相关基因表达特征特异性对少突卵瘤特异性。结论这些结果表明,由于化学化和惰性的性质,少突术术中的患者可能会衰减最大手术的益处。由于缺乏总切除术,这些患者可能不需要伴随着神经系统发病风险的侵略性手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号